Arsenite enhances the anti-tumor activity of photodynamic therapy using talaporfin sodium against U251 glioblastoma cell line

DOI
  • SHIMIZU Yuuri
    Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • YANO Yuka
    Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • FUJII Kazuna
    Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • TAKAHASHI Tsutomu
    Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • TSUNEOKA Yayoi
    Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • SHINODA Yo
    Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
  • AKIMOTO Jiro
    Department of Neurosurgery, Tokyo Medical University
  • FUJIWARA Yasuyuki
    Department of Environmental Health, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences

Bibliographic Information

Other Title
  • U251神経膠芽腫細胞株における光線力学療法の抗腫瘍効果に対する亜ヒ酸の増強効果

Abstract

<p>Glioblastoma is the most aggressive type of solid cancer that begins within the brain. We previously demonstrated that photodynamic therapy using talaporfin sodium (TS-PDT) treatment exhibits anti-tumor activity against glioblastoma. In this study, we found that sodium arsenite selectively decreased the cell viability of U251 glioblastoma cell line. Moreover, arsenite enhanced the anti-tumor activity of TS-PDT in the cells. These results suggest that arsenite has the potential to exhibit anti-tumor activity against U251 glioblastoma cell line and enhance the anti-tumor effect of TS-PDT.</p>

Journal

Details 詳細情報について

  • CRID
    1390570486221673984
  • NII Article ID
    130008073693
  • DOI
    10.14869/toxpt.48.1.0_p-14s
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top